UCL researchers launch congenital muscular dystrophy research programme
The university has been awarded a £1m grant from LifeArc and Muscular Dystrophy UK
Read More
Tag: LifeArc
New drug trial to investigate treatment for patients with bronchiectasis
200,000 people in the UK have what is considered a ‘hidden’ lung condition
Read More
Cystic fibrosis drug improves outcomes in severe COVID-19 pneumonia
Genentech’s Pulmozyme could also treat other respiratory infections and conditions
Read More
UK DRI and NHS collaborate on digitally enabled dementia care platform
Around one in five dementia hospitalisations are due to potentially preventable causes
Read More
LifeArc funds new projects to address and prevent global threat of dengue fever
The mosquito-borne viral disease is responsible for an estimated 390 million cases globally
Read More
New paediatric blood test to prevent sudden death from hereditary heart condition
Hypertrophic cardiomyopathy is a rare condition that affects up to 1,000 children in the UK
Read More
LifeArc and ALS TDI announce partnership to develop new clinical tools for ALS and MND
The project will validate two minimally invasive biomarkers for ALS: MMP-9 and TIMP-1
Read More
Researchers combine herpes virus with cancer vaccine to treat brain cancer in children
High-grade gliomas are rare, malignant tumours which account for up to 12% of all childhood brain tumours
Read More
LifeArc provides £750,000 fund for clinical trial to treat neuroferritinopathy
The progressive and incurable brain disorder currently affects approximately 100 patients worldwide
Read More
LifeArc and UKDRI invest £14.5m into neurodegeneration research
The funding will be used to develop new diagnostic tests, treatments and devices
Read More
Documentary highlights new targets to potentially treat motor neurone disease
The terminal condition currently affects around 5,000 people in the UK
Read More
New £30m initiative launched to support innovation against antimicrobial resistance
Global innovators can apply to PACE to receive up to £1m per project
Read More
- Acoramidis approved for heart condition treatment
- Genomics study launches to optimise childhood cancer care in Ireland
- UCL researchers launch congenital muscular dystrophy research programme
- Novavax shares positive real-world results for JN.1-adapted COVID-19 vaccine
- FDA approves Click’s digital therapeutic for episodic migraine
